MIA is a potential biomarker for tumour load in neurofibromatosis type 1.
Kolanczyk M, Mautner V, Kossler N, Nguyen R, Kühnisch J, Zemojtel T, Jamsheer A, Wegener E, Thurisch B, Tinschert S, Holtkamp N, Park SJ, Birch P, Kendler D, Harder A, Mundlos S, Kluwe L.
Kolanczyk M, et al. Among authors: park sj.
BMC Med. 2011 Jul 4;9:82. doi: 10.1186/1741-7015-9-82.
BMC Med. 2011.
PMID: 21726432
Free PMC article.